Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lifebank is a private stem cell biobanking company focused on collecting, processing, and cryopreserving newborn-derived biomaterials, including cord blood, placental blood, placental tissue, and umbilical cord tissue. The company markets newborn stem cell banking services to families for potential future therapeutic use, emphasizing both hematopoietic stem cells and mesenchymal stem cells. Lifebank highlights proprietary placental blood retrieval technology designed to recover additional stem cells from the placenta after birth. The business operates from a GMP, ISO-certified, AABB-accredited facility and is positioned as a commercial healthcare services and biobanking platform rather than a drug developer. It is powered by Celularity and also supports donation programs intended to facilitate stem cell research and future cellular therapy development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lifebank Stem Cell Banking.